; and (2) by adding at the end the following new subparagraph: (D) Evidence-based mobile applications for treatment of substance use disorders The model described in this subparagraph is a model to test the use of evidence-based mobile applications for the treatment of substance use disorders. . 16. Medicare hospital requirement to provide naloxone as part of the discharge protocol toindividuals being discharged after suffering an opioid overdose (a) In general Section 1866(a)(1) of the Social Security Act ( 42 U.S.C. 1395cc(a)(1) ) is amended— (1) in subparagraph (X), by striking and at the end; (2) in subparagraph (Y), by striking the period at the end and inserting , and ; and (3) by inserting after subparagraph (Y), the following new subparagraph: (Z) in the case of a hospital or critical access hospital, to provide naloxone and treatment referral options as part of the discharge protocol to individuals being discharged after suffering an opioid overdose. . (b) Effective date The amendments made by subsection (a) shall apply to contracts entered into or renewed on or after the date of the enactment of this Act. 17. Educational outreach and access to abuse-deterrent opioids (a) Access to abuse-Deterrent opioids (1) Access under Medicare part D Section 1860D–4(c) of the Social Security Act ( 42 U.S.C. 1395w–104(c) ) is amended by adding at the end the following new paragraph: (7) Access to abuse-deterrent opioids (A) In general The Secretary shall work with PDP sponsors of prescription drug plans to— (i) ensure appropriate access to abuse-deterrent opioids on plan for­mu­laries; (ii) provide advanced abuse-deterrent opioid targeting (as determined by the Secretary) for beneficiaries identified as at-risk for opioid abuse under the drug management program under paragraph (5) or any other opioid risk management program established by the sponsor